Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) Short Interest Update
Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) Short Interest Update
Receive News & Ratings for Intellipharmaceutics International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intellipharmaceutics International and related companies with MarketBeat.com's FREE daily email newsletter.Intellipharmaceutics International Inc. (OTCMKTS:IPCIF – Get Rating) (TSE:I) was the target of a large increase in short interest in the month of November. As of November 15th, there was short interest totalling 14,800 shares, an increase of 5.7% from the October 31st total of 14,000 shares. Based on an average trading volume of 3,100 shares, the short-interest ratio is currently 4.8 days.
智能制药国际公司(场外交易代码：IPCIF-GET评级)(东京证券交易所代码：I)是11月份空头股数大幅上涨的目标。截至11月15日，空头股数共有14,800股，比10月31日的14,000股增加了5.7%。以平均成交量3,100股计算，目前短息比率为4.8天。
Intellipharmaceutics International Stock Performance
IntelliPharmPharmtics International股票表现
IPCIF opened at $0.08 on Friday. Intellipharmaceutics International has a 1-year low of $0.07 and a 1-year high of $0.30. The stock's fifty day simple moving average is $0.09 and its 200 day simple moving average is $0.09.
IPCIF周五开盘报0.08美元。IntelliPharmPharmtics International的一年低点为0.07美元，一年高位为0.30美元。该股的50日简单移动均线为0.09美元，200日简单移动均线为0.09美元。
About Intellipharmaceutics International
关于英特尔制药国际公司
(Get Rating)
(获取评级)
Further Reading
进一步阅读
- Get a free copy of the StockNews.com research report on Intellipharmaceutics International (IPCIF)
- Why CSL Ltd Stock Could Be Worth a Look
- MarketBeat: Week in Review 11/28 – 12/02
- Okta Inc Celebrates Earnings Beat But Can They Sustain the Boost?
- Institutions Are Buying Ambarella, Should You?
- Can ZIM Defy Broad Downturn In The Container Shipping Industry?
- 免费获取StockNews.com关于IntelliPharmPharmtics International(IPCIF)的研究报告
- 为什么CSL有限公司的股票值得一看
- MarketBeat：回顾一周11/28-12/02
- Okta Inc.庆祝收益节节攀升，但他们能持续这种提振吗？
- 机构正在购买安巴雷拉，你应该吗？
- ZIM能否抵御集装箱航运业的普遍低迷？
Receive News & Ratings for Intellipharmaceutics International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intellipharmaceutics International and related companies with MarketBeat.com's FREE daily email newsletter.
获得IntelliPharmPharmtics International Daily的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对IntelliPharmPharmtics International和相关公司的最新新闻和分析师评级的每日简要摘要。